Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
Forma Therapeutics Holdings, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security | Security | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||
Equity | 2020 Stock Option and Incentive Plan Common Stock, $0.001 par value per share | Other (2) | 1,896,454(4) | $10.23 | $19,400,724.42 | $0.0000927 | $1,798.45 | |||||||
Equity | 2020 Employee Stock Purchase Plan Common Stock, $0.001 par value per share | Other (3) | 473,982(5) | $8.70 | $4,123,643.40 | $0.0000927 | $382.27 | |||||||
Total Offering Amounts | $23,524,367.82 | — | ||||||||||||
Total Fees Previously Paid | — | |||||||||||||
Total Fee Offsets | — | |||||||||||||
Net Fee Due | $2,180.72 |
(1) | In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions effected without the receipt of consideration which results in an increase in the number of the outstanding shares of the registrant’s common stock, $0.001 par value per share (“Common Stock”). |
(2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The price per share and aggregate offering price are calculated on the basis of $10.23, the average of the high and low price of the registrant’s Common Stock as reported on the Nasdaq Global Market on February 23, 2022. |
(3) | The price of $8.70 per share, which is 85% of the average of the high and low sale prices of the Common Stock of the registrant as quoted on the Nasdaq Global Market on February 23, 2022, is set forth solely for purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act, and has been used as these shares are without a fixed price. Pursuant to the 2020 Employee Stock Purchase Plan (the “2020 ESPP”), the purchase price of the shares of Common Stock reserved for issuance thereunder will be 85% of the fair market value of a share of Common Stock on the first trading day of the offering period or on the exercise date, whichever is less. |
(4) | Consists of 1,896,454 additional shares issuable under the 2020 Stock Option and Incentive Plan (the “2020 Plan”), which represents the automatic annual increase to the number of shares available for issuance under the 2020 Plan, effective as of January 1, 2022. Shares available for issuance under the 2020 Plan were previously registered on registration statements on Form S-8 filed with the Securities and Exchange Commission (“SEC”) on June 23, 2020 (File No. 333-239369) and March 30, 2021 (File No. 333-2554872). |
(5) | Consists of 473,982 additional shares issuable under the 2020 ESPP, which represents the automatic annual increase to the number of shares available for issuance under the 2020 ESPP effective as of January 1, 2022. Shares available for issuance under the 2020 ESPP were previously registered on registration statements on Form S-8 filed with the SEC on June 23, 2020 (File No. 333-239369) and March 30, 2021 (File No. 333-2554872). |